Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Other Non Operating Income (2016 - 2025)

Altimmune (ALT) has disclosed Other Non Operating Income for 16 consecutive years, with -$27000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 122.88% to -$27000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$190000.0 through Dec 2025, down 495.83% year-over-year, with the annual reading at -$190000.0 for FY2025, 495.83% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$27000.0 at Altimmune, up from -$86000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $118000.0 in Q4 2024, with the low at -$286000.0 in Q3 2021.
  • Average Other Non Operating Income over 5 years is -$19100.0, with a median of $14500.0 recorded in 2023.
  • Peak annual rise in Other Non Operating Income hit 542.33% in 2021, while the deepest fall reached 1078.85% in 2021.
  • Over 5 years, Other Non Operating Income stood at -$81000.0 in 2021, then plummeted by 167.9% to -$217000.0 in 2022, then skyrocketed by 109.22% to $20000.0 in 2023, then skyrocketed by 490.0% to $118000.0 in 2024, then plummeted by 122.88% to -$27000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$27000.0, -$86000.0, and -$92000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.